Marco Meglio, Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at mmeglio@neurologylive.com
New Relapsing MS Trial Seeks to Compare Stem Cell Transplant With Biologic Drugs
January 7th 2020The trial will determine whether autologous hematopoietic stem cell transplantation is a more appropriate treatment option for patients with severe forms of relapsing MS compared to currently available biologic drugs.
Trial Will Assess Blood-Based Biomarker to Distinguish Epileptic From Psychogenic Seizures
December 15th 2019A new trial will aim to confirm the findings of a previous study that showed novel combinations of peripherally circulating proteins coupled with risk factors can provide a diagnostic tool with significant clinical unity.